Modulation of ion channel function by P2Y receptors
- PMID: 12835530
- DOI: 10.1385/CBB:39:1:75
Modulation of ion channel function by P2Y receptors
Abstract
P2Y receptors are classified as P2 purinergic receptors that belong to the superfamily of G-protein coupled receptors. They are distinguishable from P1 (adenosine) receptors in that they bind adenine and/or uracil nucleotide triphosphates or diphosphates depending on the subtype. Over the past decade, P2Y receptors have been cloned from a variety of tissues and species. Eight functional subtypes have been characterized. Nucleotide binding produces activation of specific G-proteins that in turn regulate the function of membrane bound enzymes including phospholipase C and adenylyl cyclase. Certain P2Y receptor subtypes possess a PDZ domain located at the end of the C-terminal region of the receptor. PDZ domains have been established as sites for protein-protein interaction, thus providing a possible mechanism for receptor modulation of membrane protein function independent of G-protein activation. In this review we discuss recent findings that suggest that P2Y receptors can modulate the function of ion channels through multiple protein-protein interactions at the plasma membrane that do not directly involve G-protein activation.
Similar articles
-
Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors.Mol Pharmacol. 2004 Sep;66(3):468-77. doi: 10.1124/mol.66.3.. Mol Pharmacol. 2004. PMID: 15322238
-
Two-pore potassium ion channels are inhibited by both G(q/11)- and G(i)-coupled P2Y receptors.Mol Cell Neurosci. 2010 Apr;43(4):363-9. doi: 10.1016/j.mcn.2010.01.003. Epub 2010 Jan 22. Mol Cell Neurosci. 2010. PMID: 20097289
-
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.Pharmacol Ther. 2006 Jun;110(3):415-32. doi: 10.1016/j.pharmthera.2005.08.014. Epub 2005 Oct 28. Pharmacol Ther. 2006. PMID: 16257449 Review.
-
Different structural requirements for functional ion pore transplantation suggest different gating mechanisms of NMDA and kainate receptors.J Neurochem. 2008 Oct;107(2):453-65. doi: 10.1111/j.1471-4159.2008.05623.x. Epub 2008 Aug 14. J Neurochem. 2008. PMID: 18710418
-
A retrospective of recombinant P2Y receptor subtypes and their pharmacology.Arch Biochem Biophys. 2002 Jan 1;397(1):131-6. doi: 10.1006/abbi.2001.2616. Arch Biochem Biophys. 2002. PMID: 11747319 Review.
Cited by
-
Apical membrane P2Y4 purinergic receptor controls K+ secretion by strial marginal cell epithelium.Cell Commun Signal. 2005 Nov 2;3:13. doi: 10.1186/1478-811X-3-13. Cell Commun Signal. 2005. PMID: 16266433 Free PMC article.
-
Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells.Front Endocrinol (Lausanne). 2020 May 22;11:329. doi: 10.3389/fendo.2020.00329. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32528416 Free PMC article. Review.
-
Purine-based infochemicals and immunometabolites: a comparative review of emerging signaling pathways in plants and animals.FEMS Microbiol Rev. 2025 Jan 14;49:fuaf029. doi: 10.1093/femsre/fuaf029. FEMS Microbiol Rev. 2025. PMID: 40650573 Free PMC article. Review.
-
Interaction of P2 purinergic receptors with cellular macromolecules.Naunyn Schmiedebergs Arch Pharmacol. 2008 Mar;377(1):1-33. doi: 10.1007/s00210-007-0222-2. Epub 2007 Dec 19. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18273661 Free PMC article. Review.
-
P2Y purinergic receptor regulation of CFTR chloride channels in mouse cardiac myocytes.J Physiol. 2004 May 1;556(Pt 3):727-37. doi: 10.1113/jphysiol.2003.059881. Epub 2004 Feb 20. J Physiol. 2004. PMID: 14978203 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous